Patents, Pills, and the Press: The Rise and Fall of the Global HIV/AIDS Medicines Crisis in the News (Global Crises and the Media)

Patents, Pills, and the Press: The Rise and Fall of the Global HIV/AIDS Medicines Crisis in the News (Global Crises and the Media) image
ISBN-10:

1433123509

ISBN-13:

9781433123504

Author(s): OWEN, Thomas
Edition: New
Released: May 30, 2015
Format: Hardcover, 217 pages
to view more data

Description:

HIV/AIDS is a global health crisis of unprecedented proportions. Afflicting millions worldwide, its social, political, economic, and ethical dimensions have rendered explicit the vast inequalities of our «negatively globalized planet». Since the late 1990s, a major feature of the crisis has been the dispute over intellectual property protection and medicines access.
In this book, Thomas Owen examines the mediatization of this dispute. Weaving together contemporary media theory and interdisciplinary research with computer-assisted news analysis and interviews with journalists and civil society campaigners, the book illuminates the intersecting constitutive relationships between global crises, global governance, and global media. In a context of changing media technologies, logics, and practices, this book observes where the mediatized conflict surrounding global medicines access has at times consolidated elite political economic power, and at other times provided civil society campaigners their greatest opportunities for global social change.
With an interdisciplinary approach, this book is suitable for courses on global media communication and global journalism, as well as advanced undergraduate and postgraduate courses in public health communication, political communication, social movement studies, and international relations.


























We're an Amazon Associate. We earn from qualifying purchases at Amazon and all stores listed here.

Want a Better Price Offer?

Set a price alert and get notified when the book starts selling at your price.

Want to Report a Pricing Issue?

Let us know about the pricing issue you've noticed so that we can fix it.